ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,604Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 546

$529K Total Retail Price of All Prescriptions

Rank: 48 out of 546

383 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 383 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

12% of this provider’s 383 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 6,602 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
LEVOTHYROXINE SODIUM 509 458 1 3
SIMVASTATIN 436 349 2 2
METOPROLOL TARTRATE 297 281 3 6
LISINOPRIL 290 233 4 1
AMLODIPINE BESYLATE 242 221 5 9
OMEPRAZOLE 220 185 6 4
HYDROCODONE-ACETAMINOPHEN 185 98 S3 7 8
FUROSEMIDE 179 135 8 5
PANTOPRAZOLE SODIUM 178 98 9 18
HYDROCHLOROTHIAZIDE 162 144 10 7
SERTRALINE HCL 158 137 11 14
ATENOLOL 155 113 12 12
ATORVASTATIN CALCIUM 140 128 13 11
METFORMIN HCL 136 95 14 10
LOSARTAN POTASSIUM 127 107 15 24
NAMENDA 105 105 16 60
TRAMADOL HCL 101 61 17 19
RISPERIDONE 99 92 18 47
DONEPEZIL HCL 98 98 19 31
TAMSULOSIN HCL 94 94 20 35
CITALOPRAM HBR 90 44 21 21
WARFARIN SODIUM 79 65 22 13
GLIPIZIDE 73 48 23 44
TERAZOSIN HCL 73 73 23 83
TRAZODONE HCL 70 39 25 25
ADVAIR DISKUS 69 61 26 20
ALLOPURINOL 68 54 27 41
FLUOXETINE HCL 62 47 28 39
PROAIR HFA 62 36 28 27
VENTOLIN HFA 58 45 30 63
OXYCODONE HCL 58 22 S2 30 15
LOVASTATIN 57 57 32 22
HALOPERIDOL 55 55 33 102
JANUVIA 55 44 33 79
AZITHROMYCIN 55 32 33 55
GLYBURIDE 55 49 R 33 45
ALENDRONATE SODIUM 55 51 33 38
METOPROLOL SUCCINATE 53 53 38 17
LACTULOSE 53 50 38 96
FINASTERIDE 52 52 40 94
RANITIDINE HCL 52 42 40 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 1, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.